Marcyrl Pharmaceutical Industries
Mina Attia is an experienced professional in the pharmaceutical industry, currently serving as a Senior First Line Manager and Sales Supervisor at Marcyrl Pharmaceutical Industries since October 2011. Promoted to Sales Supervisor in March 2019, Mina oversees a team of 10 medical representatives and has successfully launched two strategic cardiovascular products in 2021. Prior experience includes working as a Medical Sales Representative at UNIPHARMA Egypt from January 2007 to September 2011. Mina Attia holds a Bachelor of Science degree in Chemistry and Microbiology from Sohag University, completed in 2006.
This person is not in any offices
Marcyrl Pharmaceutical Industries
Marcyrl Group, One of the Leading Global Pharmaceutical Companies, EU GMP-Certified Egyptian manufacturers provide innovative diversified specialty care treatments in different therapeutic areas, with a strong presence covering Africa and GCC, CIS, and LATAM to deliver cost-effective critical solutions to healthcare practitioners and their patients across the continents. At Marcyrl, we are working to transform the way specialty treatments are made accessible worldwide, ensuring that specialty care treatments are of high quality and available to those who need them the most, has secured investment from Development Partners International (DPI) and Amethis.